Orvaten

Orvaten Uses, Dosage, Side Effects, Food Interaction and all others data.

An ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension.

Orvaten is a prodrug, i.e., the therapeutic effect of orally administered midodrine is due to the major metabolite desglymidodrine formed by deglycination of midodrine. Administration of midodrine results in a rise in standing, sitting, and supine systolic and diastolic blood pressure in patients with orthostatic hypotension of various etiologies. Standing systolic blood pressure is elevated by approximately 15 to 30 mmHg at 1 hour after a 10-mg dose of midodrine, with some effect persisting for 2 to 3 hours. Orvaten has no clinically significant effect on standing or supine pulse rates in patients with autonomic failure.

Trade Name Orvaten
Availability Prescription only
Generic Midodrine
Midodrine Other Names Midodrin, Midodrina, Midodrine, Midodrinum
Related Drugs phenylephrine, norepinephrine, ephedrine, Levophed, droxidopa, ProAmatine
Weight 10mg, 2.5mg, 5mg,
Type Oral Tablet, Oral
Formula C12H18N2O4
Weight Average: 254.2823
Monoisotopic: 254.126657074
Groups Approved
Therapeutic Class
Manufacturer
Available Country United States
Last Updated: September 19, 2023 at 7:00 am
Orvaten
Orvaten

Uses

Orvaten is an alpha-adrenergic antagonist used to treat orthostatic hypotension.

For the treatment of symptomatic orthostatic hypotension (OH).

Orvaten is also used to associated treatment for these conditions: Symptomatic Orthostatic Hypotension

How Orvaten works

Orvaten undergoes metabolism to form its pharmacologically active metabolite, desglymidodrine. Desglymidodrine acts as an agonist at the alpha1-adrenergic receptors expressed in the arteriolar and venous vasculature. Activation of alpha1-adrenergic receptor signaling pathways lead to an increase in the vascular tone and elevation of blood pressure. Desglymidodrine is reported to have negligible effect on the cardiac beta-adrenergic receptors.

Toxicity

Symptoms of overdose could include hypertension, piloerection (goosebumps), a sensation of coldness and urinary retention. The single doses that would be associated with symptoms of overdosage or would be potentially life- threatening are unknown. The oral LD50 is approximately 30 to 50 mg/kg in rats, 675 mg/kg in mice, and 125 to 160 mg/kg in dogs. Desglymidodrine is dialyzable.

Food Interaction

  • Take with or without food. The absorption is unaffected by food.

Orvaten Hypertension interaction

[Major] Orvaten can cause marked elevation of supine blood pressure (BP>200 mmHg systolic) and should not be used in patients with persistent and excessive supine hypertension.

Systolic elevations of this degree are most likely to be observed in patients with relatively elevated pre-treatment systolic blood pressures (mean 170 mmHg).

There is no experience in patients with initial supine systolic pressure above 180 mmHg, as those patients were excluded from the clinical trials.

Use of midodrine in such patients is not recommended.

Additionally, care should be taken when using this agent in orthostatic hypotensive patients who are also diabetic.

Supine and sitting hypertension should be evaluated at the beginning of therapy, and blood pressure (supine, sitting, and orthostatic) should be monitored regularly.

Elimination Route

Rapidly absorbed following oral administration. The peak plasma concentrations of the prodrug, desglymidodrine, is reached about half an hour following drug administration. The metabolites reach their peak plasma concentrations at about 1 to 2 hours following drug administration. The absolute bioavailability of midodrine (measured as desglymidodrine) is 93% and is not affected by food. As desglymidodrine displays poor diffusibility across the blood-brain barrier, it is expected to have minimal effects on the central nervous system.

Half Life

The metabolites display a half-life of about 3 to 4 hours.

Clearance

  • Renal cl=385 mL/minute

Innovators Monograph

You find simplified version here Orvaten

http://classyfire.wishartlab.com/tax_nodes/C0000000
http://classyfire.wishartlab.com/tax_nodes/C0002448
http://classyfire.wishartlab.com/tax_nodes/C0002279
http://classyfire.wishartlab.com/tax_nodes/C0004113
http://classyfire.wishartlab.com/tax_nodes/C0004111
http://classyfire.wishartlab.com/tax_nodes/C0004742
http://classyfire.wishartlab.com/tax_nodes/C0000138
http://classyfire.wishartlab.com/tax_nodes/C0000128
http://classyfire.wishartlab.com/tax_nodes/C0001661
http://classyfire.wishartlab.com/tax_nodes/C0003633
http://classyfire.wishartlab.com/tax_nodes/C0002484
http://classyfire.wishartlab.com/tax_nodes/C0004557
http://classyfire.wishartlab.com/tax_nodes/C0000469
http://classyfire.wishartlab.com/tax_nodes/C0004150
http://classyfire.wishartlab.com/tax_nodes/C0003073
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6933
http://www.hmdb.ca/metabolites/HMDB0014356
http://www.genome.jp/dbget-bin/www_bget?drug:D08220
http://www.genome.jp/dbget-bin/www_bget?cpd:C07890
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4195
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46507373
https://www.chemspider.com/Chemical-Structure.4050.html
https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=6963
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=6933
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201212
http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000229
http://www.pharmgkb.org/drug/PA164749381
http://www.rxlist.com/cgi/generic3/midodrine.htm
https://www.drugs.com/cdi/midodrine.html
https://en.wikipedia.org/wiki/Midodrine
*** Taking medicines without doctor's advice can cause long-term problems.
Share